ArticleACS omega2025
Quantitative SERS-Based Sandwich-Hybridization Assay for Nucleic Acid Detection.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surface-enhanced Raman spectroscopy (SERS) has great potential for quantifying biological molecules, particularly DNA. In this study, we developed a SERS-based sandwich-hybridization assay for detecting DNA corresponding to viral (SARS-CoV-2) RNA using commercially available components and standard bioconjugation procedures; hence, no sophisticated synthesis steps were required. The assay employs TAMRA-labeled DNA conjugated to gold nanoparticles as nanoprobes and biotin-labeled surface DNA strands. Upon hybridization with the target analyte, the complete sandwich structure forms and is captured on a neutravidin-coated glass via the avidin-biotin interaction. The observed Raman signals originate from the TAMRA reporter dye, leveraging signal enhancement from both resonance and plasmonic effects, enabling the sensitive detection of the target analyte. Quantification of target DNA was performed using both a conventional single-point peak-height spectral analysis and a binary image-based analysis, with the latter providing a reliable evaluation of the assay's performance. Additionally, atomic force microscopy (AFM) was employed to characterize the samples, and the strong correlation between AFM and SERS results confirms the accuracy and reliability of this approach.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.